Healthcare & Medical: Pressemitteilungen - Kategorie - Seite 6

Healthcare & Medical

Category / Healthcare & Medical


Where is the next Chinese drug that will make MNCs compete to grab orders?

HONG KONG: HONG KONG, Jan 9, 2025 - (ACN Newswire) – The trading of TCE (T Cell Engager) bispecific antibodies remains hot, and multinational pharmaceutical companies (MNCs) are still placing orders franticall ...

Vivalytic Bacterial Meningitis by Bosch: PCR rapid test for medical emergencies

Waiblingen: The test covers the most important bacterial pathogens across all age groups with a single cartridge - The Vivalytic test is a PCR rapid test that specifically detects the six most common causes o ...

Grünenthal appoints Prof. Dr. Uli Brödl as Chief Scientific Officer

Aachen, Germany: Grünenthal announced today that Prof. Dr. Uli Brödl will assume the role of Chief Scientific Officer (CSO) and Member of the Corporate Executive Board, effective 01 February 2025. Uli Brödl has m ...

175 years of Heidelberger Druckmaschinen: Company starts anniversary year with growth strategy

Heidelberg: - Growth strategy: medium-term sales potential of more than € 300 million - Growth drivers in the core business: packaging, digital printing Software and lifecycle business - Industrial busine ...

Everest Medicines Announces the Implementation of NEFECON National Reimbursement Drug List Pricing in China for the Treatment for IgA Nephropathy

SHANGHAI: SHANGHAI, China - January 2, 2025 - (ACN Newswire) - Everest Medicines (HKEX 1952.HK, 'Everest', or the 'Company'), a biopharmaceutical company focused on the discovery, clinical d ...

Worlds first high-standard negative-pressure isolation ward built with MiC technology completes historical mission

HONG KONG: Laid solid foundation for modular design in isolation facility construction technology ...

Olympus Named to Dow Jones Sustainability World Index for the Fourth Consecutive Year

TOKYO: TOKYO, Dec 24, 2024 - (JCN Newswire) - Olympus Corporation (Olympus), a global MedTech company committed to making people’s lives healthier, safer and more fulfilling, today announced that it has be ...

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Philippines: - by the National Medical Products Administration of China for the Treatment of Moderately to Severely Active Ulcerative Colitis ...

Breast Implants and Health Risks: Why Regular Screening Matters

Klosterneuburg, Austria: Lack of follow-up care for breast implants leads to delayed detection of ruptures. A new study highlights the risk of serious long-term consequences and calls for greater awareness. ...

Gerresheimer: FDA grants Tentative Approval of SQ Innovation’s Lasix® ONYU*

Düsseldorf: - Innovative combination product of furosemide and on-body device - Ready-to-market device designed, developed and manufactured by Gerresheimer - Patented device technology for precise administr ...

New Advances in Carbon Ion Therapy for Challenging Large Tumours

Klosterneuburg, Austria: Groundbreaking findings on treatment optimization for large sacral chordomas. Researchers at MedAustron Ion Therapy Center and Karl Landsteiner University of Health Sciences improve methods for energy ...

Everest Medicines: Accelerating Innovation in Renal Disease to Forge a Path Toward Biopharma Leadership

HONG KONG: HONG KONG, Dec 11, 2024 - (ACN Newswire) – As reported by the South China Morning Post today, Everest Medicines (HKEX 1952.HK) is accelerating its journey to become a leading biopharmaceutical compa ...

The Future of Nutrition: Dr. Clemens Röhrl on Regional Plant Research and Its Importance for Health and the Environment

Freising: Why is the cultivation of regional foods crucial for reducing carbon dioxide emissions? How can innovative research on apple varieties help combat allergies? Dr. Clemens Röhrl, project leader of the ...

Everest Medicines Announces Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of EVER001, a Novel BTK Inhibitor for the Treatment of Primary Membranous Nephropathy

SHANGHAI: - Patients in the low-dose cohort who have completed 36 weeks of treatment, 9 out of 11 (81.8%) achieved overall clinical remission and 10 out of 11 (91%) achieved immunological complete remission. - ...

Everest Medicines Announces Acceptance of VELSIPITY New Drug Application in Hong Kong

SHANGHAI: SHANGHAI, Dec 2, 2024 - (ACN Newswire) - Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, ...

Strides Pharma Consolidates European Business-to-Business Operations in Switzerland

Zug, Switzerland: - Market proximity of Strides Pharma International AG, based in Zug, Switzerland, opens the way for rapid technology transfer and innovation within the European market - Oren Weininger, longstan ...

NEFECON(R) Included in National Reimbursement Drug List (NRDL)

HONG KONG: - Significantly Boosting Market Penetration and Driving Valuation Reassessment ...

First European Patient Congress Depression for those affected by depression and their close relations takes place online on December 7, 2024 / Free online-event offers information and experience-sharing

Frankfurt am Main: The European Patient Congress Depression, hosted by the European Alliance Against Depression (EAAD), will take place on December 7, 2024. This free online-event is designed to support individuals affe ...


Seite 7 von 356:  « ..  6 7 8  9  10  11  12  13  14  15  .. » 356





 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z